KRT18P51

Across TCGA pan-cancer cohorts, KRT18P51 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated KRT18P51 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher KRT18P51 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated KRT18P51 expression acts as an unfavorable survival marker, although some lineages such as READ and CESC show a favorable association.

LUAD, CHOL, and READ are the cancer types where KRT18P51 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	All	0.584	0.732	<.001	134	view →
CHOL	DFS	Median	II,III,IV	0.097	0.590	.004	39	view →
READ	DFS	Quartile	III,IV	0.977	0.413	<.001	38	view →
KICH	DFS	Quartile	All	0.325	0.938	.006	35	view →
PAAD	OS	Quartile	II,III,IV	0.469	0.655	.006	21	view →
CESC	OS	Median	All	0.923	0.833	.016	20	view →
ESCA	OS	Median	All	0.647	1.000	.015	18	view →
ACC	DFS	Tertile	IV	0.012	0.310	.002	18	view →
MESO	OS	Tertile	III,IV	0.251	0.422	.016	15	view →
BLCA	DFS	Median	All	0.616	0.366	.003	13	view →
STAD	DFS	Tertile	All	0.379	0.683	.032	13	view →
GBM	DFS	Tertile	All	0.053	0.297	<.001	12	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

KRT18P51–LUAD (OS)

Open the LUAD breakdown →